Imaging post-177Lu-peptide receptor radionuclide therapy in a child with advanced progressive somatostatin-receptor-positive medulloblastoma

Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):937-939. doi: 10.1007/s00259-020-04966-w. Epub 2020 Aug 7.

Authors

Milena Pizzoferro¹, Bartolomeo Cassano², Claudio Altini³, Antonella Cacchione⁴, Maria Giuseppina Cefalo⁴, Vittorio Cannatà², Maria Carmen Garganese³

Affiliations

¹ Nuclear Medicine Unit/Imaging Department, IRCCS Bambino Gesù Children's Hospital, Piazza Sant'Onofrio 4, 00165, Rome, Italy. [email protected].
² Medical Physics Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
³ Nuclear Medicine Unit/Imaging Department, IRCCS Bambino Gesù Children's Hospital, Piazza Sant'Onofrio 4, 00165, Rome, Italy.
⁴ Paediatric Haematology/Oncology Department, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

PMID: 32767090
DOI: 10.1007/s00259-020-04966-w

No abstract available

Publication types

Case Reports

MeSH terms

Cerebellar Neoplasms* / diagnostic imaging
Cerebellar Neoplasms* / radiotherapy
Child
Humans
Medulloblastoma* / diagnostic imaging
Medulloblastoma* / radiotherapy
Neuroendocrine Tumors* / diagnostic imaging
Neuroendocrine Tumors* / radiotherapy
Octreotide / therapeutic use
Organometallic Compounds*
Radioisotopes
Receptors, Peptide
Receptors, Somatostatin

Substances

Organometallic Compounds
Radioisotopes
Receptors, Peptide
Receptors, Somatostatin
Octreotide